What does Acoumed do?

Acoumed is a specialist medical practice in Roeselare. Private Limited, started on 17 April 2018, 2 establishments.

What is the address of Acoumed?

The registered office of Acoumed is located at Bergeikenstraat 58, 8800 Roeselare.

Is Acoumed still active?

Yes. According to the CBE (29 October 2026) Acoumed is active, legal situation “Normale toestand”, started on 17 April 2018.

Is Acoumed registered on Peppol?

Yes, Acoumed is registered on the Peppol network with ID 0208:0694839011.

What is the enterprise number of Acoumed?

The enterprise number of Acoumed is BE0694839011.

When was Acoumed founded?

Acoumed was founded on 17 April 2018.

Who are the directors of Acoumed?

According to the 2025 annual accounts, the directors of Acoumed are: Willem-Jan Acou.

Is Acoumed a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Acoumed make in 2025?

Acoumed posted a profit after taxes of € 381,867 in financial year 2025.

What is the revenue of Acoumed?

As a small company, Acoumed is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 532,465.

Acoumed (Private Limited) - Roeselare - BE0694839011

Dossier Acoumed, printed on 29 October 2026 from databakkes.be/en/0694839011/acoumed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Acoumed from Roeselare, company number BE0694839011, closed financial year 2025 with a result of € 381,867 after tax. For that financial year Acoumed recorded a gross margin of € 532,465 and equity of € 501,018. Compared with financial year 2024, the result moved from € 405,394 to € 381,867. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 501,018

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 381,867

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 69,637

▲ € 63,444 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 380,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 41,913

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 818

▼ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 63,403

▼ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 415,793 Gross margin 2022: € 415,793 First fiscal year in the series	€ 475,523 Gross margin 2023: € 475,523 ▲ 14% vs 2022 (€ 415,793) Favourable step	€ 545,367 Gross margin 2024: € 545,367 ▲ 15% vs 2023 (€ 475,523) Favourable step	€ 532,465 Gross margin 2025: € 532,465 ▼ 2% vs 2024 (€ 545,367) Unfavourable step	▼ 2%
Profit after taxes	€ 304,486 Profit after taxes 2022: € 304,486 First fiscal year in the series	€ 348,867 Profit after taxes 2023: € 348,867 ▲ 15% vs 2022 (€ 304,486) Favourable step	€ 405,394 Profit after taxes 2024: € 405,394 ▲ 16% vs 2023 (€ 348,867) Favourable step	€ 381,867 Profit after taxes 2025: € 381,867 ▼ 6% vs 2024 (€ 405,394) Unfavourable step	▼ 6%
Equity	€ 484,889 Equity 2022: € 484,889 First fiscal year in the series	€ 473,757 Equity 2023: € 473,757 ▼ 2% vs 2022 (€ 484,889) Unfavourable step	€ 499,151 Equity 2024: € 499,151 ▲ 5% vs 2023 (€ 473,757) Favourable step	€ 501,018 Equity 2025: € 501,018 Unchanged (€ 499,151) Favourable step
Total debts	€ 197,206 Total debts 2022: € 197,206 First fiscal year in the series	€ 395,793 Total debts 2023: € 395,793 ▲ 101% vs 2022 (€ 197,206) Unfavourable step	€ 335,795 Total debts 2024: € 335,795 ▼ 15% vs 2023 (€ 395,793) Favourable step	€ 310,852 Total debts 2025: € 310,852 ▼ 7% vs 2024 (€ 335,795) Favourable step	▼ 7%
Cash	€ 33,389 Cash 2022: € 33,389 First fiscal year in the series	€ 43,663 Cash 2023: € 43,663 ▲ 31% vs 2022 (€ 33,389) Favourable step	€ 6,192 Cash 2024: € 6,192 ▼ 86% vs 2023 (€ 43,663) Unfavourable step	€ 69,637 Cash 2025: € 69,637 ▲ € 63,444 vs 2024 (€ 6,192) Favourable step	▲ € 63,444
Retained profit	€ 466,339 Retained profit 2022: € 466,339 First fiscal year in the series	€ 455,207 Retained profit 2023: € 455,207 ▼ 2% vs 2022 (€ 466,339) Unfavourable step	€ 480,601 Retained profit 2024: € 480,601 ▲ 6% vs 2023 (€ 455,207) Favourable step	€ 482,468 Retained profit 2025: € 482,468 Unchanged (€ 480,601) Favourable step
Dividend	€ 300,000 Dividend 2022: € 300,000 First fiscal year in the series	€ 360,000 Dividend 2023: € 360,000 ▲ 20% vs 2022 (€ 300,000) Unchanged	€ 380,000 Dividend 2024: € 380,000 ▲ 6% vs 2023 (€ 360,000) Unchanged	€ 380,000 Dividend 2025: € 380,000 Unchanged (€ 380,000) Unchanged
Balance sheet total	€ 682,095 Balance sheet total 2022: € 682,095 First fiscal year in the series	€ 869,550 Balance sheet total 2023: € 869,550 ▲ 27% vs 2022 (€ 682,095) Unchanged	€ 834,946 Balance sheet total 2024: € 834,946 ▼ 4% vs 2023 (€ 869,550) Unchanged	€ 811,870 Balance sheet total 2025: € 811,870 ▼ 3% vs 2024 (€ 834,946) Unchanged	▼ 3%

Key figures of Acoumed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Acoumed?

What happened at Acoumed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 381,867 (▼ 6% vs 2024). Source: NBB ↗
Apr 17, 2018 New establishment in Roeselare. KBO
Apr 17, 2018 New establishment in Roeselare. KBO
Apr 17, 2018 Start of the company according to the CBE. KBO

In short

From € 304,486 profit in 2022 to € 381,867 profit in 2025.

Paid € 490,749 in corporate taxes since 2022.

Best year ever: 2024, with € 405,394 profit.

Paid out € 1.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Willem-Jan Acou

Acoumed

CARDIOLOGIE AZ DELTA

Behind Acoumed is Willem-Jan Acou. Willem-Jan Acou is also behind CARDIOLOGIE AZ DELTA.

Directors

According to the 2025 annual accounts

Willem-Jan Acou

Director

Also active at: CARDIOLOGIE AZ DELTA

Establishments

Establishment units

Physical locations of this company

Registered office

Bergeikenstraat 58

8800 Roeselare

2.277.792.404

Wilgenstraat 2

8800 Roeselare

Active since 17 April 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0694.839.011

VAT number

BE 0694.839.011

Registered office

Bergeikenstraat 58, 8800 Roeselare

Names & denominations

Acoumed

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 April 2018

Peppol

Active · Active since 17 Jul 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van hoofdkantoren

View on CBE Public ↗ Annual accounts (NBB) ↗

Acoumed

Financials

What happened to Acoumed?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions